All the news Showing 4 of 4 articles from: Treatment and HCV genotypeGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Shortened duration triple therapy fails in genotype 3 HCV Healio Hepatology / 24 April 2017 Optimism About HCV Treatment Comes With Caveats Medscape / 22 March 2017 Gilead Seeks FDA Approval for Hep C Treatment for All Genotypes Manual Items / 02 November 2015 Gilead Announces SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir (SOF) and Velpatasvir (VEL) (GS-5816) for the Treatment of All Six Hepatitis C Genotypes Gilead press release / 21 September 2015 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive